A comprehensive view of BioNTech SE. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna brings Pfizer/BioNTech to court in London claiming patent breach over COVID-19 vaccine technology; Pfizer and BioNTech deny the allegations and call for two Moderna patents to be declared invalid
Published: April 23, 2024 by AFP World News
BioNTech to report first quarter 2024 financial results and corporate update on May 6, 2024
Published: April 22, 2024 by BioNTech SE
Biontech SE and Tron Translationale Onkologie an Der Univ Der Johannes Gutenberg Univ Mainz Gemeinnuetzige Submit Korean Patent Application for Treatment Involving Interleukin-2 (IL2) and Interferon (IFN)
Published: April 19, 2024 by Pharmaceutical Patent News
Australia: BioNTech SE Receives Patent for 'Dose determination for immunotherapeutic agents'
Published: April 19, 2024 by Australian Government
Biontech SE Seeks Patent for Process for the Preparation of a Substituted Imidazoquinoline
Published: April 18, 2024 by Chemical Patent News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count